Gut bacteria may help pancreatic surgery recovery
NCT ID NCT07422103
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a probiotic called Clostridium butyricum CBM588 can reduce diarrhea and improve quality of life in people who have had their pancreas removed due to cancer or other growths. About 158 patients will take either the probiotic or a placebo for three months after surgery. The main goal is to see if it reduces daily bowel movements.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Clostridium butyricum CBM588 (a probiotic)
- What this could lead to
- If it works, this probiotic could become a simple, safe way to ease diarrhea and improve gut health after pancreatic surgery.
- What could go wrong
- This is an early-stage trial with no phase designation, so results are uncertain. The probiotic may not improve symptoms more than a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CBM588 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ospedale Pederzoli
Peschiera del Garda, Verona, 37019, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can pancreatic Cancer's inflammatory footprint be stopped?
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?